Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase

The cellular response to an inflammatory stressor requires a proinflammatory cellular activation followed by a controlled resolution of the response to restore homeostasis. We hypothesized that biliverdin reductase (BVR) by binding biliverdin (BV) quells the cellular response to endotoxin-induced in...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 108; no. 46; pp. 18849 - 18854
Main Authors Wegiel, Barbara, Gallo, David, Csizmadia, Eva, Roger, Thierry, Kaczmarek, Elzbieta, Harris, Clair, Zuckerbraun, Brian S, Otterbein, Leo E
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 15.11.2011
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The cellular response to an inflammatory stressor requires a proinflammatory cellular activation followed by a controlled resolution of the response to restore homeostasis. We hypothesized that biliverdin reductase (BVR) by binding biliverdin (BV) quells the cellular response to endotoxin-induced inflammation through phosphorylation of endothelial nitric oxide synthase (eNOS). The generated NO, in turn, nitrosylates BVR, leading to nuclear translocation where BVR binds to the Toll-like receptor-4 (TLR4) promoter at the Ap-1 sites to block transcription. We show in macrophages that BV-induced eNOS phosphorylation (Ser-1177) and NO production are mediated in part by Ca2+/calmodulin-dependent kinase kinase. Furthermore, we show that BVR is S-nitrosylated on one of three cysteines and that this posttranslational modification is required for BVR-mediated signaling. BV-induced nuclear translocation of BVR and inhibition of TLR4 expression is lost in macrophages derived from Enos–/– mice. In vivo in mice, BV provides protection from acute liver damage and is dependent on the availability of NO. Collectively, we elucidate a mechanism for BVR in regulating the inflammatory response to endotoxin that requires eNOS-derived NO and TLR4 signaling in macrophages.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved October 5, 2011 (received for review June 28, 2011)
Author contributions: B.W., D.G., B.S.Z., and L.E.O. designed research; B.W., D.G., E.C., E.K., C.H., and B.S.Z. performed research; E.C. and T.R. contributed new reagents/analytic tools; B.W. and L.E.O. analyzed data; and B.W., and L.E.O. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1108571108